New COVID-19 nasal spray outperforms current antibody treatments in mice - Northwestern Now

A single inhaled dose treated or even prevented infection by COVID-19 and its variants

A new protein-based antiviral nasal spray developed by researchers at Northwestern University, University of Washington and Washington University at St. Louis is being advanced toward Phase I human c… [+6038 chars]

full article...